Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP3 | P08254 | 8/20 | 0.52 |
| ▸ | MMP2 | P08253 | 7/20 | 0.52 |
| ▸ | MMP1 | P03956 | 2/20 | 0.51 |
| ▸ | MMP9 | P14780 | 2/20 | 0.51 |
| ▸ | MMP14 | P50281 | 2/20 | 0.51 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.33 |
| ▸ | KIF11 | P52732 | 1/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.32 |
| ▸ | SCD5 | Q86SK9 | 1/20 | 0.31 |
| ▸ | QDPR | P09417 | 1/20 | 0.31 |
| ▸ | USP5 | P45974 | 1/20 | 0.30 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6585173 | 0.90 | MMP3 (0.50) | MMP3MMP2MMP1MMP9MMP14 | |
| SCHEMBL6586307 | 0.90 | MMP3 (0.62) | MMP3MMP2MMP1MMP9MMP14 | |
| SCHEMBL6438199 | 0.81 | MMP3 (0.62) | MMP3MMP2MMP1MMP9MMP14 | |
| SCHEMBL6587603 | 0.80 | MMP2 (0.48) | MMP3MMP2SCN9A | |
| SCHEMBL6432618 | 0.79 | MMP2 (0.67) | MMP3MMP2MMP1MMP9MMP14 | |
| SCHEMBL6584658 | 0.78 | MMP2 (0.51) | MMP3MMP2MMP1MMP9MMP14 | |
| SCHEMBL6587846 | 0.78 | MMP2 (0.83) | MMP3MMP2MMP1MMP9MMP14 | |
| SCHEMBL6437658 | 0.76 | MMP2 (0.51) | MMP3MMP2MMP1MMP9MMP14 | |
| SCHEMBL6586333 | 0.76 | MMP2 (0.85) | MMP3MMP2MMP1MMP9MMP14 | |
| SCHEMBL6436990 | 0.76 | MMP3 (0.69) | MMP3MMP2MMP1MMP9MMP14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1036062-B1 | HYDROXAMIC ACID DERIVATIVES AS MATRIX METALLOPROTEASE (MMP) INHIBITORS | PFIZER LTD (GB) | 2004-01-02 | — | — | EP | disclosed |
| US-6495568-B1 | TREATMENT OF TISSUE ULCERATION, WOUND REPAIR AND SKIN DISEASES | WARNER-LAMBERT COMPANY | 2002-12-17 | — | — | US | disclosed |
| EP-1036062-A1 | HYDROXAMIC ACID DERIVATIVES AS MATRIX METALLOPROTEASE (MMP) INHIBITORS | Pfizer Limited (GB) | 2000-09-20 | — | — | EP | disclosed |
| WO-1999029667-A1 | HYDROXAMIC ACID DERIVATIVES AS MATRIX METALLOPROTEASE (MMP) INHIBITORS | PFIZER LIMITED (GB) | 1999-06-17 | — | — | WO | disclosed |